Fuxing China Group, a long-established Chinese manufacturer of zippers and fastening products, has withdrawn its planned $8 million U.S. IPO, halting what would have...
Exact Sciences Corporation (EXAS), a global leader in cancer detection and diagnostics, has announced plans for a $1 billion follow-on public offering to strengthen...
Gloo Holdings, a Christian-focused digital platform, has priced its initial public offering at $8 per share, below the previously indicated range of $9–$11. The...
Nuvation Bio Inc., a clinical-stage biotechnology company developing next-generation cancer therapies, is preparing a $140 million initial public offering (IPO) to advance its portfolio...
Terns Pharmaceuticals, Inc., a rapidly emerging clinical-stage biotechnology company focused on developing small-molecule therapies for obesity and oncology, is preparing a $150 million initial...